How can high-throughput screening technology platforms effectively improve in vitro diagnostic efficiency?

Basic Concepts and Value of High-Throughput Screening

High-throughput screening refers to a technical mode in which a large number of samples or indicators are processed in parallel within the same workflow, commonly used in scenarios such as infectious disease screening, blood nucleic acid screening, and autoimmune marker detection. Its core value lies in completing more testing tasks per unit time through standardized workflows and automated equipment, while reducing errors caused by manual operations. In the field of in vitro diagnostics, high-throughput screening is not equivalent to definitive diagnosis, but serves as an important means of risk stratification and preliminary screening of suspected samples.

Mainstream Technology Platforms and Sample Processing Methods

Currently, the more widely used high-throughput screening platforms mainly include microplate enzyme-linked immunosorbent assay, chemiluminescence immunoassay, real-time fluorescence quantitative PCR arrays, and nucleic acid extraction workstations. Common microplate specifications include 96-well and 384-well formats, and some automated platforms can support continuous operation of multiple plates. The sample processing step generally requires the use of sample tubes with unique identifiers, combined with automated liquid handling systems to perform dispensing, mixing, transfer, and other operations, so as to reduce the risk of cross-contamination.

Key Points of Data Reading and Quality Control

High-throughput screening generates a large amount of raw data, which needs to be uniformly collected and interpreted through a laboratory information management system. Quality control usually includes setting up negative controls, positive controls, and internal reference materials, and monitoring inter-batch variation and plate position effects. Due to the large number of screening samples, performance drift in any single reagent lot may affect the stability of overall results; therefore, quality control materials need to be used regularly to verify system status.

Application Directions and Development Trends

In the future, high-throughput screening will be more often combined with multiplex detection, microfluidic chips, and automated assembly lines, improving indicator resolution while maintaining throughput. For clinical or public health projects, selecting a technology platform and reagent combination suitable for the intended use is more important than simply pursuing a high number of channels.